MNK Therapy in Releasing the Superficial Fascia for Patients With AAS: an Assessor-blinded, Randomised Controlled Trial
The goal of this type of randomized controlled trial, employing a blinded evaluator methodology, to verify the clinical efficacy and safety of MNK therapy. This aims to provide a reference for clinical practitioners and AAS patients in their decision-making process.

Participants will randomly allocated into two groups using a random number table method, with forty patients in each group. The experimental group (Group 1) underwent MNK therapy to release the superficial fascia, while the control group (Group 2) received conventional acupuncture treatment.
- EligibilityCriteria: Inclusion Criteria:  16 to 55 years old Clear history of trauma within 1 to 7 days Presence of localized swelling, pain, bruising, and limping symptoms in the ankle joint Pain in the ankle joint upon resistance No accompanying fractures Diagnosis of acute ankle injury according to the "Diagnostic and Therapeutic Criteria of Traditional Chinese Medicine" No prior treatment before participating in this therapy Willingness to participate in this study and signing of the informed consent form  Exclusion Criteria:  Individuals with clear indications for surgery Those suffering from gout, rheumatoid arthritis, joint tuberculosis, joint tumors, etc. Pregnant or breastfeeding women Individuals with serious primary diseases of the cardiovascular, liver, kidney, brain, and hematopoietic systems Those with local skin lesions or skin diseases Individuals with coagulation dysfunction Those with severe fear of needles Individuals unwilling to comply with the treatment regimen - HealthyVolunteers: No - Gender: All - MinimumAge: 16 Years - MaximumAge: 55 Years - StdAgeList: Child, Adult